Fulgent Genetics Inc. (NASDAQ:FLGT) changes shares on Thursday trading session, with a change of 2.39% or $0.39 shares. The trading starts at $16.22 and closed at $16.33 throughout the day. The trading session low price was $16.22 and day high was $17.03 on Thursday, June 18. After the session, the Healthcare sector daily volume shifted to 0.33 million while its average volume is 410.39K. In other hand, the FLGT market cap reached to $346.10M. While, its current target price is $16.72 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 10.00% and down -1.99% for month. Its quarterly performance was 75.26% above, while its half year performance is up 27.83%. FLGT yearly performance stood at positive 186.23% and rise 29.61% for year-to-date. Current recommendation for Fulgent Genetics Inc. is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. FLGT EPS (TTM) for 12-month is -0.01. EPS for this year is 93.00%, while for the next year its value is 0.27. Its EPS Q/Q reached 13.30%. It has an EPS of 17.30% up for past five years and for the next five years will be up 44.45%.
Let’s take a look on the analyst recommendations on FLGT for the current month and previous month. For the current month, 2 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $11.00-$21.00. Average target price for FLGT was reached at $17.33.
Driehaus Capital Management, LLC, Baker Brothers Advisors, LLC and Vanguard Group, Inc. (The) are the top three holders in Fulgent Genetics Inc. (FLGT) stock. On Mar 30, 2020, Driehaus Capital Management, LLC has 0.67 million shares which valued 7.19 million. On Mar 30, 2020, Baker Brothers Advisors, LLC owned 0.57 million shares which valued at 6.13 million. On Mar 30, 2020, Vanguard Group, Inc. (The) has a total of 0.49 million shares which valued at 5.27 million. In the end, Vanguard Group, Inc. (The) have 2.26% shares outstanding of Fulgent Genetics Inc. (FLGT) on Mar 30, 2020. The insider ownership moved to 38.40% and institutional holding shifted to 29.80%.
The company posted an EPS (TTM) of -0.01. According to the most recent quarter report on (Jun 2020), 2 analysts estimated an average EPS of -0.04, while 0.06 EPS posted a year ago period. Analyst Estimated EPS for FLGT published in the report was -0.05–0.03 during the same period. Comparing with last year, the average estimated EPS was 0.06 which is higher than -0.03 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for FLGT rise 25.49% for period of 200 days. SMA for 50 days was 7.51% which is showing green signal, while SMA-20 was 1.59%. The moving average value for Fulgent Genetics Inc. (FLGT) is 14.24 and 16.24 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in FLGT stock. On Jun 02, KIM PAUL, CFO and Treasurer, sold 425 trading shares at the cost of $18.06, which valued at 7674.0. On May 22, BOLGER JOHN C, Director, sold 8,677 shares at the cost of $15.36, with total shares of 3,296. On May 12, KIM PAUL, CFO and Treasurer, sold 1,421 shares at the cost of 16.31. After this transaction, KIM PAUL total shares reached to 434,238 which valued at 23176.0.